CN Stock MarketDetailed Quotes

605077 Zhejiang Huakang Pharmaceutical

Watchlist

15.47
+0.01+0.06%

Not Open Mar 11 15:00 CST

4.73BMarket Cap17.62P/E (TTM)

Zhejiang Huakang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Huakang Pharmaceutical Q4 2024 Earnings Date

Currency：CNYFeb 28, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	702.63M	--
		-5.13%
Net Income	--	81.40M	--
		-16.25%

Analyst Rating

Strong Buy

Mar 11, 2025

Zhejiang Huakang Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2026/FY	-- / 4.356B	--
--	2025/FY	-- / 3.672B	--
Feb 28, 2025	2024/FY	2.808B / 3.267B	--
--	2023/FY	2.783B / 2.660B	--

DatePeriodRevenue/EstimateEarnings Call

--2026/FY-- / 4.356B--

--2025/FY-- / 3.672B--

Feb 28, 20252024/FY2.808B / 3.267B--

--2023/FY2.783B / 2.660B--

--------

Unlock Free Earnings Estimates

Open Account

Zhejiang Huakang Pharmaceutical Earnings Reports

Huakang Co., Ltd.: Summary of Huakang\'s 2024 Annual Report

Feb 27 11:00 ET

Huakang shares: Huakang shares 2024 annual report

Feb 27 11:00 ET

Huakang Co., Ltd. 2024 Annual Report

Feb 27 11:00 ET

Summary of Huakang Co., Ltd. 2024 Annual Report

Feb 27 11:00 ET

Symbol Price % Chg

Yong Jie New Material

Geovis Insighter Technology

920116

126.20 +21.91%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Mar 11, 2025

Strong Buy

Strong Buy
75.00%
Buy
25.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Sugar Substitute (sweetener)

Intraday+1.18%

Food and Drink Concept

Intraday+1.03%

ShangHai Stock Connect

Intraday+0.42%